Abstract
Hypoxia inducible factor-1α is an important transcription factor which is necessary for hypoxic gene expression that responds to changes in oxygen level in cell. HIF-1α remained stable and active in the occurance of Fe2+ and oxygen but it is depleted through the Von Hippel Lindau protein (pVHL) or Ubiquitin or Proteosome pathway. Restriction of oxygen induces inhibition of prolyl hydroxylase and accumulation of HIF-1α which in turn translocates to the nucleus to form a heterodimer with HIF-1β. Chronic hypoxia stimulates both KLF6 and NF-κB gene expressions and it reduces KLF4 which further enhances8 iNOS expression. Over expression of iNOS leads to rise in NO production and increase formation of peroxynitrite (ONOO–). This event will lead to swelling of mitochondria and release cytochrome. Among the various heavy metals lead (Pb) is found to be a potent inducer of oxidative free radicals along with suppressor of cellular antioxidant defense system. The mechanism involves destruction of glutathione or inhibition of sulfhydryl dependent enzymes or altering intracellular oxidant and antioxidant balance which greatly affect cellular integrities. Heavy metals like lead (Pb), nickel (Ni) and cobalt (Co) can activate the hypoxia signaling pathways through Akt/ERK1/2 and induce HIF-1α accumulation.
This review analyzed the significant impact of sustained hypoxia in physiological system alone or along with simultaneous exposure of lead and possible protective role of vitamin C as antioxidant in rats.
Keywords: HIF-1α, hypoxia, NOS, oxidative stress, Pb, VEGF, vitamin C.
Graphical Abstract
Current Signal Transduction Therapy
Title:Hypoxia, Lead Toxicities and Oxidative Stress: Cell Signaling, Molecular Interactions and Antioxidant (Vitamin C) Defense
Volume: 9 Issue: 3
Author(s): Kusal K. Das and Sikha Saha
Affiliation:
Keywords: HIF-1α, hypoxia, NOS, oxidative stress, Pb, VEGF, vitamin C.
Abstract: Hypoxia inducible factor-1α is an important transcription factor which is necessary for hypoxic gene expression that responds to changes in oxygen level in cell. HIF-1α remained stable and active in the occurance of Fe2+ and oxygen but it is depleted through the Von Hippel Lindau protein (pVHL) or Ubiquitin or Proteosome pathway. Restriction of oxygen induces inhibition of prolyl hydroxylase and accumulation of HIF-1α which in turn translocates to the nucleus to form a heterodimer with HIF-1β. Chronic hypoxia stimulates both KLF6 and NF-κB gene expressions and it reduces KLF4 which further enhances8 iNOS expression. Over expression of iNOS leads to rise in NO production and increase formation of peroxynitrite (ONOO–). This event will lead to swelling of mitochondria and release cytochrome. Among the various heavy metals lead (Pb) is found to be a potent inducer of oxidative free radicals along with suppressor of cellular antioxidant defense system. The mechanism involves destruction of glutathione or inhibition of sulfhydryl dependent enzymes or altering intracellular oxidant and antioxidant balance which greatly affect cellular integrities. Heavy metals like lead (Pb), nickel (Ni) and cobalt (Co) can activate the hypoxia signaling pathways through Akt/ERK1/2 and induce HIF-1α accumulation.
This review analyzed the significant impact of sustained hypoxia in physiological system alone or along with simultaneous exposure of lead and possible protective role of vitamin C as antioxidant in rats.
Export Options
About this article
Cite this article as:
K. Das Kusal and Saha Sikha, Hypoxia, Lead Toxicities and Oxidative Stress: Cell Signaling, Molecular Interactions and Antioxidant (Vitamin C) Defense, Current Signal Transduction Therapy 2014; 9 (3) . https://dx.doi.org/10.2174/1574362410666150225232258
DOI https://dx.doi.org/10.2174/1574362410666150225232258 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Case Report of Antitubercular Drugs Induced Exanthematous Reaction Complicated by Acute Onset Levofloxacin Induced Toxic Epidermal Necrolysis (TEN)
Current Drug Safety Therapeutic Neovascularization by the Implantation of Autologous Mononuclear Cells in Patients with Connective Tissue Diseases
Current Pharmaceutical Design Therapeutic Potential of Non-Coding RNAs and TLR Signalling Pathways in Rheumatoid Arthritis
Current Pharmaceutical Biotechnology Privileged Structures - Dream or Reality: Preferential Organization of Azanaphthalene Scaffold
Current Medicinal Chemistry Rheumatoid Arthritis: Genetic Variants as Biomarkers of Cardiovascular Disease
Current Pharmaceutical Design Emerging Role of Antioxidants in the Protection of Uveitis Complications
Current Medicinal Chemistry Identification of Target Antigens of Antiendothelial Cell Antibodies Against Human Brain Microvascular Endothelial Cells in Healthy Subjects
Current Neurovascular Research Promising Pharmacological, Molecular and Cellular Treatments of Autoimmune Hepatitis
Current Pharmaceutical Design A Review of the Diagnostic Scope of Biomarker Techniques, Genetic Screening and Virtual Scanning
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Inhibition of Interleukin-1 in the Treatment of Selected Cardiovascular Complications
Current Reviews in Clinical and Experimental Pharmacology The Role of Autophagy in Rheumatic Disease
Current Drug Targets Editorial: Cocaine and Acute Basilar Artery Occlusion: What we Know to Date?
Current Vascular Pharmacology Pediatric CKD and Cardivascular Disease
Cardiovascular & Hematological Disorders-Drug Targets Angiotensin 1-7 Promotes Cardiac Angiogenesis Following Infarction
Current Vascular Pharmacology Nontuberculous Mycobacterium Infections in Rheumatoid Arthritis Patients: The Serodiagnosis of Pulmonary Disease due to Mycobacterium avium Complex with an Enzyme Immunoassay Kit Detecting Glycopeptidolipid Core Antigen (Capilia MAC Antibody ELISA)<sup>®</sup>)
Current Rheumatology Reviews Adverse Drug Reactions: Trends in a Tertiary Care Hospital
Current Drug Safety Pathological Features of Antibody-Mediated Rejection
Current Drug Targets - Cardiovascular & Hematological Disorders Gastroenterological Complications of Anderson-Fabry Disease
Current Pharmaceutical Design Bacterial Zinc Proteases and their Inhibition
Current Enzyme Inhibition Unravelling the Role of Infectious Agents in the Pathogenesis of Human Autoimmunity: The Hypothesis of the Retroviral Involvement Revisited
Current Molecular Medicine